GCG and metabolic dysfunction-associated steatohepatitis: In our cohort of non-diabetic NAFLD/NASH patients, we observed impaired GLP-1 secretion in response to oGTT with consequences for insulin, glucagon and glucose dynamics in comparison to a healthy control group.